GU Oncology Research Fellow @DanaFarber | MD @lebamericanuni | Aspiring Oncologist 🧬 | Healthcare advocate | he/him
Joined March 2024
- Tweets 157
- Following 172
- Followers 123
- Likes 164
15 Photos and videos
It won’t be the same without @MarcMachaalani @RazaneHChehade. You’ll be missed.
Jun 8
Hard to believe that these 2 super-stars Drs. @RazaneHChehade @MarcMachaalani are moving on after an amazing 3-yr postdoc fellowships in the @DanaFarber_GU labs
Both @PittPediatrics and @YaleIMed are very lucky to have you! Please don’t become @steelers fan or @Yale 🏈 fan!
1
7
1,116
Wassim Daoud Khatoun retweeted
Hard to believe that @RazaneHChehade is moving on after a productive postdoc fellowship in the lab. Best of luck on your next steps - @PittPediatrics is very fortunate to have you, and I can't wait to see what you accomplish next!
2
6
39
3,518
Wassim Daoud Khatoun retweeted
Jun 4
Detecting lung cancer 5 years before it happens, in @CellCellPress courtesy of the @CharlesSwanton group.
Astonishing translational work !
cell.com/action/showPdf?pii=…
4
90
333
26,621
Wassim Daoud Khatoun retweeted
Jun 3
Congrats to the whole team @DanaFarber_GU on this new @AACR paper in Molecular Cancer Research
This is the result of over 4 years of work with 3 labs @DanaFarber, where @adib_elio @AminNassarMD @sarahaboualaiwi were residents/fellows @BrighamMedRes @YaleCancer and @SylvanBacaLab was a post-doc!
Thank you @MichelleDunno17 @SashaGusevPosts @mouwlab for being the best collaborators!
Link: aacrjournals.org/mcr/article…
3
32
99
11,616
Wassim Daoud Khatoun retweeted
Jun 2
Wrapping up my first #ASCO, from presenting in an oral session to meeting inspiring pioneers in oncology.
Grateful for the mentorship and leadership of @DrChoueiri and the @DanaFarber_GU team.
@OncoAlert @ASCO
9
46
3,132
Wassim Daoud Khatoun retweeted
Jun 2
Impressive results from a phase 3 trial of Iza-Bren (anti-HER3/EGFR TOPO1 ADC) vs chemo in pretreated mTNBC, with improvement in PFS and OS. High rate of hematologic toxicities, including 5% febrile neutropenia. Phase 3 ongoing to confirm these results in a global population.
3
37
96
28,053
Wassim Daoud Khatoun retweeted
Jun 2
Highlight of #ASCO26
Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: nej.md/4nWaxvM
@ASCO
ALT Graph from a study published in the New England Journal of Medicine on daraxonrasib versus chemotherapy for metastatic pancreatic cancer. The x-axis represents months, and the y-axis shows the percentage of patients alive. Two lines indicate survival rates: daraxonrasib (blue) and chemotherapy (gray). The bottom section lists patients at risk over time. Title and journal logo are included.
1
2
455
Wrapping up an incredible #ASCO26. From cancer screening to ctDNA, clinical trials, and health equity, every session left me energized and inspired. Can’t wait for #ASCO27!
@ASCO @DanaFarber_GU @DanaFarber @OncoAlert
1
1
17
599
Wassim Daoud Khatoun retweeted
Jun 2
2
20
76
10,645
Wassim Daoud Khatoun retweeted
Published today and presenting tomorrow! 📚➡️🎤
Excited to share our @ASCO Ed Book chapter on the contemporary challenges of EOC care @KimmieNgMD @drtarahenderson #IreneSu
Looking forward to tomorrow’s discussion at #ASCO26
ascopubs.org/doi/10.1200/EDB…
21
40
3,416
Wassim Daoud Khatoun retweeted
May 31
Brian Wolpin, MD, MPH, presents positive results from the RASolute 302 trial showing a substantial prolongation of survival for patients with previously treated metastatic pancreatic cancer, regardless of RAS mutation status, taking daraxonrasib, an investigational oral RAS(ON) multi-selective inhibitor, compared with chemotherapy. #ASCO26
3
35
134
59,405
As we celebrate #Pride, it’s vital to remember the global challenges faced by #LGBTQIA individuals. Discrimination in healthcare & difficulty accessing it are major obstacles to advancing equitable health.
Read our paper from Lebanon: tinyurl.com/yckccpsb
Happy Pride! 🌈🏳️⚧️
2
6
286
Exciting to see some of the work on leptomeningeal disease done at @MSKCancerCenter. Posters highlighting CSF-based CTC analysis in predicting outcomes in NSCLC by @mjeng21, and genomic correlates of LMD after brain metastasis resection by @roshalp.
@ASCO #ASCO26 @MSK_RadOnc
4
14
1,930
Powerful reminder from Dr. #HIreneSu at #ASCO26 that oncofertility care should reach every young cancer patient equitably. Closing disparity gaps is an essential part of survivorship care.
@ASCO @UCSDHealth @OncoAlert @crisbergerot #YoungOnsetCancer #CancerSurvivorship
4
9
466
Comprehensive reminder by @crisbergerot at #ASCO26: effective early-onset cancer care is not just about treatment—it requires integrating psychosocial care, reproductive health, survivorship services, patient navigation, and financial counseling. @OncoAlert
1
6
8
326
Insightful talk by @DanaFarber’s Dr. @KimmieNgMD at #ASCO26 on the rising burden of young-onset cancers, highlighting the birth-cohort effect and the efforts to uncover the roles of the exposome, microbiome, immunity, and environmental exposures in young-onset #CRC. @OncoAlert
5
18
1,070
Wassim Daoud Khatoun retweeted
Cheers, chills, and a standing ovation when RASolute 302 showed unprecedented survival on daraxonrasib for patients with progressive pancreatic cancer
Seldom do you sense you’re witnessing a historic moment in cancer care but this feels like ras targeting has arrived
#ASCO26
92
1,273
6,503
1,151,077
Wassim Daoud Khatoun retweeted
May 31
This is not simply a new pancreatic cancer drug.
It is a reminder that even “undruggable” biology can become treatable with persistence.
Daraxonrasib doubled median OS vs chemotherapy in RAS G12 metastatic pancreatic cancer: 13.2 vs 6.6 months.
A remarkable ASCO moment.
#ASCO26
@DrChoueiri @TiansterZhang @CathyEngMD @montypal @tompowles1 @brian_rini @cdanicas @GlopesMd @PGrivasMDPhD @nataliagandur @yekeduz_emre @neerajaiims @ASCO @ONCOassist @OpenMedicineHQ @MedwatchKate @scserendipity1 @CParkMD @urotoday @OncLive @crisbergerot @urologysummit @SuyogCancer @Larvol @IMG_Oncologists
24
277
1,355
192,680
Wassim Daoud Khatoun retweeted
This curve brought me to tears.
I treated a patient on this trial, and it took his terrible pain away completely within days, which is simply not common.
This represents decades of scientific perseverance and millions of patients who will now live longer and with less pain. 👏🏻
26
176
1,379
82,442
Honored to have presented our poster today at #ASCO26 about the role of CARINH in predicting progression in mccRCC. Grateful for the exemplary mentorship of @DrChoueiri and @BraunMDPhD!
@ASCO @DanaFarber_GU @DanaFarber @OncoAlert @IMG_Oncologists
8
29
2,534